Literature DB >> 22467522

Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population.

Yoshinobu Ishitobi1, Shinya Nakayama, Kana Yamaguchi, Masayuki Kanehisa, Haruka Higuma, Yoshihiro Maruyama, Taiga Ninomiya, Shizuko Okamoto, Yoshihiro Tanaka, Jusen Tsuru, Hiroaki Hanada, Koichi Isogawa, Jotaro Akiyoshi.   

Abstract

Major depressive disorder (MDD) and panic disorder (PD) are common and disabling medical disorders with stress and genetic components. Dysregulation of the stress response of the hypothalamic-pituitary-adrenal axis, including the corticotrophin-releasing hormone (CRH) signaling via primary receptors (CRHR1 and CRHR2), is considered to play a major role for onset and recurrence in MDD and PD. To confirm the association of CRHR1 and CRHR2 with MDD and PD, we investigated 12 single nucleotide polymorphisms (SNPs) (rs4076452, rs7209436, rs110402, rs242924, rs242940, and rs173365 for CRHR1 and rs4722999, rs3779250, rs2267710, rs1076292, rs2284217, and rs226771 for CRHR2) in MDD patients (n = 173), PD patients (n = 180), and healthy controls (n = 285). The SNP rs110402 and rs242924 in the CRHR1 gene and the rs3779250 in the CRHR2 gene were associated with MDD. The SNP rs242924 in the CRHR1 gene was also associated with PD. The T-A-T-G-G haplotype consisting of rs7209436 and rs173365 in CRHR1 was positively associated with MDD. The T-A haplotype consisting of rs7209436 and rs110402 in CRHR1 was positively associated with MDD. The C-C haplotype consisting of rs4722999 and rs37790 in CRHR1 was associated with PD. These results provide support for an association of CRHR1 and CRHR2 with MDD and PD.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467522     DOI: 10.1002/ajmg.b.32046

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  30 in total

Review 1.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

2.  Drug addiction and stress-response genetic variability: association study in African Americans.

Authors:  Orna Levran; Matthew Randesi; Yi Li; John Rotrosen; Jurg Ott; Miriam Adelson; Mary Jeanne Kreek
Journal:  Ann Hum Genet       Date:  2014-04-26       Impact factor: 1.670

3.  Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women.

Authors:  Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Donald E Humphries; Mark W Miller
Journal:  Depress Anxiety       Date:  2013-10-09       Impact factor: 6.505

4.  Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.

Authors:  Alexa Orand; Bruce Naliboff; Malin Gadd; Wendy Shih; Tiffany Ju; Angela P Presson; Emeran A Mayer; Lin Chang
Journal:  Psychoneuroendocrinology       Date:  2016-07-19       Impact factor: 4.905

Review 5.  Hormonal Treatments for Major Depressive Disorder: State of the Art.

Authors:  Jennifer B Dwyer; Awais Aftab; Rajiv Radhakrishnan; Alik Widge; Carolyn I Rodriguez; Linda L Carpenter; Charles B Nemeroff; William M McDonald; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2020-05-27       Impact factor: 18.112

6.  The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder.

Authors:  Ana Martín-Blanco; Marc Ferrer; Joaquim Soler; Maria Jesús Arranz; Daniel Vega; Natalia Calvo; Matilde Elices; Cristina Sanchez-Mora; Iris García-Martinez; Juliana Salazar; Cristina Carmona; Joana Bauzà; Mónica Prat; Víctor Pérez; Juan C Pascual
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-17       Impact factor: 5.270

7.  Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults.

Authors:  Pamela Belmonte Mahon; Peter P Zandi; James B Potash; Gerald Nestadt; Gary S Wand
Journal:  Psychopharmacology (Berl)       Date:  2012-12-30       Impact factor: 4.530

8.  The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.

Authors:  Christian Grillon; Elizabeth Hale; Lynne Lieberman; Andrew Davis; Daniel S Pine; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

9.  Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing.

Authors:  H Weber; J Richter; B Straube; U Lueken; K Domschke; C Schartner; B Klauke; C Baumann; C Pané-Farré; C P Jacob; C-J Scholz; P Zwanzger; T Lang; L Fehm; A Jansen; C Konrad; T Fydrich; A Wittmann; B Pfleiderer; A Ströhle; A L Gerlach; G W Alpers; V Arolt; P Pauli; H-U Wittchen; L Kent; A Hamm; T Kircher; J Deckert; A Reif
Journal:  Mol Psychiatry       Date:  2015-09-01       Impact factor: 15.992

Review 10.  The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders.

Authors:  Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2015-08-31       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.